MA
Maximilian Alexander Boehmer
About Maximilian Alexander Boehmer
Data last updated:
Maximilian Alexander Boehmer is a Director at Fresenius Kabi Oncology Limited (since 2023). The company operates in Pharma. Fresenius Kabi Oncology Limited reported revenue of ₹848 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Fresenius Kabi Oncology Limited U24231DL2003PLC119441 | Director | 29 Aug 2023 | 2003 | ₹848 Cr (FY 2025) | Active |
Board colleagues of Maximilian Alexander Boehmer
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arvind Kumar Sharma | 08144338 | Fresenius Kabi Oncology Limited | Managing Director |
| Eduardo Ricardo Dos Santos Montanha | 08158265 | Fresenius Kabi Oncology Limited | Additional Director |
| Heike Susanne Van Dawen | 10645045 | Fresenius Kabi Oncology Limited | Director |
| Nikhil Kulshreshtha | 07178027 | Fresenius Kabi Oncology Limited | Nodal Officer |
| Nikhil Kulshreshtha | Fresenius Kabi Oncology Limited | Company Secretary | |
| Rahul Sharma | Fresenius Kabi Oncology Limited | Cfo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Maximilian Alexander Boehmer
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maximilian Alexander Boehmer
Maximilian Alexander Boehmer currently holds 1 directorship: Fresenius Kabi Oncology Limited (Director, since 29 Aug 2023, revenue ₹848 Cr (FY 2025)).
Maximilian Alexander Boehmer was first appointed on 29 Aug 2023 as Director at Fresenius Kabi Oncology Limited.
The current boards of Maximilian Alexander Boehmer's companies include Arvind Kumar Sharma (Fresenius Kabi Oncology Limited), Eduardo Ricardo Dos Santos Montanha (Fresenius Kabi Oncology Limited), Heike Susanne Van Dawen (Fresenius Kabi Oncology Limited), Nikhil Kulshreshtha (Fresenius Kabi Oncology Limited), Nikhil Kulshreshtha (Fresenius Kabi Oncology Limited), Rahul Sharma (Fresenius Kabi Oncology Limited).